Free Trial
→ This Signal Only Flashes Once Every 4 Years – And It Just Triggered (From Crypto Swap Profits) (Ad) Free BBIO Stock Alerts

BridgeBio Pharma (BBIO) SEC Filings & 10K Form

BridgeBio Pharma logo
$43.64 +0.81 (+1.88%)
As of 11:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent BridgeBio Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
07/01/2025
6:48 PM		BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
6:49 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13D/A
07/01/2025
3:31 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
3:31 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2025
4:54 PM		BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
4:46 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4/A
06/30/2025
4:49 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4/A
06/30/2025
4:51 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
4:08 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
3:13 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2025
3:14 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2025
3:16 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2025
3:19 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/24/2025
6:06 PM		BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:06 PM		BridgeBio Pharma (Issuer)
DANIELS RONALD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:07 PM		AGUIAR ERIC (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:07 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:10 PM		BridgeBio Pharma (Issuer)
Cook Jennifer E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:12 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
6:13 PM		BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:56 PM		BridgeBio Pharma (Issuer)
Hassan Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:56 PM		BridgeBio Pharma (Issuer)
HOMCY CHARLES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:57 PM		BridgeBio Pharma (Issuer)
MOMTAZEE JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:54 PM		BridgeBio Pharma (Issuer)
Scott Randal W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:55 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
5:55 PM		BridgeBio Pharma (Issuer)
Dachille Douglas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2025
4:59 PM		BridgeBio Pharma (Subject)
MCCORMICK FRANK (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/23/2025
3:29 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
4:00 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
5:06 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:05 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
4:07 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
3:25 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
4:24 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:52 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SCHEDULE 13D/A
05/12/2025
8:46 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:00 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
3:40 PM		BridgeBio Pharma (Filer)
Form DEFA14A
05/06/2025
3:42 PM		BridgeBio Pharma (Issuer)
Lo Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
3:45 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
5:01 AM		BridgeBio Pharma (Filer)
Form DEF 14A
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
04/30/2025
5:02 AM		BridgeBio Pharma (Filer)
Form ARS
04/16/2025
4:39 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:06 PM		BridgeBio Pharma (Filer)
Form PRE 14A
04/14/2025
3:21 PM		BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2025
4:11 PM		BridgeBio Pharma (Issuer)
Ellis Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
3:48 PM		BridgeBio Pharma (Subject)
Ellis Andrea (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
3:54 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:32 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:09 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
5:03 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:28 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13D/A
03/10/2025
3:43 PM		BridgeBio Pharma (Issuer)
Valantine Hannah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:09 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
5:15 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SCHEDULE 13D/A
03/06/2025
3:06 PM		BridgeBio Pharma (Subject)
Valantine Hannah (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
8:09 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
7:22 PM		Apuli Maricel (Reporting)
BridgeBio Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
4:36 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
3:35 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2025
6:31 AM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2025
7:48 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:50 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
7:51 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM		BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
3:31 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
4:23 PM		BridgeBio Pharma (Subject)
Kumar Neil (Filed by)
Form SCHEDULE 13G/A
01/31/2025
6:18 PM		BridgeBio Pharma (Issuer)
HALVORSEN OLE ANDREAS (Reporting)
Ott David C. (Reporting)
Shabet Rose Sharon (Reporting)
VIKING GLOBAL INVESTORS LP (Reporting)
Viking Global Opportunities GP LLC (Reporting)
Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting)
Viking Global Opportunities Parent GP LLC (Reporting)
Viking Global Opportunities Portfolio GP LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
6:18 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
6:18 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SCHEDULE 13D/A
01/30/2025
5:29 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
5:31 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:18 PM		BridgeBio Pharma (Subject)
STEPHENSON BRIAN C (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/28/2025
3:18 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
3:53 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:43 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4/A
12/31/2024
4:52 PM		BridgeBio Pharma (Issuer)
Satvat Ali J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:18 PM		BridgeBio Pharma (Issuer)
MCCORMICK FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:05 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2024
6:00 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
8:16 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:57 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2024
7:00 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:06 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:13 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:15 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:24 PM		BridgeBio Pharma (Subject)
Kumar Neil (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
10:44 AM		BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
11/06/2024
4:04 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
Top Picks for Trump’s Pro-Crypto America (Ad)

Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…

Claim your pass to the Crypto Community Summit here (free for a limited time)
10/22/2024
5:06 PM		BlackRock, Inc. (Filed by)
BridgeBio Pharma (Subject)
Form SC 13G/A
09/17/2024
5:44 PM		BridgeBio Pharma (Issuer)
KKR & Co. Inc. (Reporting)
KKR Genetic Disorder GP LLC (Reporting)
KKR Genetic Disorder L.P. (Reporting)
KKR Group Co. Inc. (Reporting)
KKR Group Holdings Corp. (Reporting)
KKR Group Partnership L.P. (Reporting)
KKR Management LLP (Reporting)
KRAVIS HENRY R (Reporting)
ROBERTS GEORGE R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
5:41 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Filed by)
Form SC 13D/A
09/13/2024
4:04 PM		BridgeBio Pharma (Subject)
KKR Genetic Disorder L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
7:16 PM		BridgeBio Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
7:42 PM		BridgeBio Pharma (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
Form SC 13D/A
08/20/2024
5:24 PM		BridgeBio Pharma (Issuer)
Trimarchi Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:27 PM		BridgeBio Pharma (Issuer)
STEPHENSON BRIAN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
5:31 PM		BridgeBio Pharma (Issuer)
Kumar Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BBIO) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...
Crypto 101 Media | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored